Trial Profile
Efficacy of Dexmedetomidine as Adjuvant to Intrathecal Bupivacaine in Decreasing Incidence of Post Spinal Shivering in Parturients Undergoing Caesarean Section
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2024
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Bupivacaine; Bupivacaine; Fentanyl
- Indications Perioperative pain; Shivering
- Focus Therapeutic Use
- 31 Aug 2016 Status changed from not yet recruiting to completed.
- 27 Sep 2012 New trial record